Suppr超能文献

相似文献

1
MicroRNA-886-3P functions as a tumor suppressor in small cell lung cancer.
Cancer Biol Ther. 2018;19(12):1185-1192. doi: 10.1080/15384047.2018.1491505. Epub 2018 Sep 19.
2
DNA methylation-mediated repression of miR-886-3p predicts poor outcome of human small cell lung cancer.
Cancer Res. 2013 Jun 1;73(11):3326-35. doi: 10.1158/0008-5472.CAN-12-3055. Epub 2013 Apr 16.
5
MicroRNA signature of small-cell lung cancer after treatment failure: impact on oncogenic targets by miR-30a-3p control.
Mol Oncol. 2023 Feb;17(2):328-343. doi: 10.1002/1878-0261.13339. Epub 2022 Nov 23.
7
MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
J Exp Clin Cancer Res. 2016 May 10;35:76. doi: 10.1186/s13046-016-0357-4.
8
LncRNA LUADT1 sponges miR-15a-3p to upregulate Twist1 in small cell lung cancer.
BMC Pulm Med. 2019 Dec 16;19(1):246. doi: 10.1186/s12890-019-0991-7.
9
Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer.
Lung Cancer. 2012 Apr;76(1):32-8. doi: 10.1016/j.lungcan.2011.10.002. Epub 2011 Nov 1.

引用本文的文献

2
The small noncoding RNA is dispensable to mouse development.
RNA. 2024 Oct 16;30(11):1465-1476. doi: 10.1261/rna.080161.124.
3
The small non-coding RNA is dispensable to mouse development.
bioRxiv. 2024 Jun 5:2024.06.01.596958. doi: 10.1101/2024.06.01.596958.
4
Non-coding 886 (/), the epigenetic odd duck - implications for future studies.
Epigenetics. 2024 Dec;19(1):2332819. doi: 10.1080/15592294.2024.2332819. Epub 2024 Mar 25.
5
Non-Coding RNAs as Key Regulators in Lung Cancer.
Int J Mol Sci. 2023 Dec 31;25(1):560. doi: 10.3390/ijms25010560.
6
The uprise of RNA biology in neuroendocrine neoplasms: altered splicing and RNA species unveil translational opportunities.
Rev Endocr Metab Disord. 2023 Apr;24(2):267-282. doi: 10.1007/s11154-022-09771-4. Epub 2022 Nov 24.
9
MicroRNAs Involved in Small-cell Lung Cancer as Possible Agents for Treatment and Identification of New Targets.
Cancer Genomics Proteomics. 2021 Sep-Oct;18(5):591-603. doi: 10.21873/cgp.20283.

本文引用的文献

1
Immune-based Therapies for Non-small Cell Lung Cancer.
Anticancer Res. 2017 Feb;37(2):377-387. doi: 10.21873/anticanres.11330.
2
mir-660-p53-mir-486 Network: A New Key Regulatory Pathway in Lung Tumorigenesis.
Int J Mol Sci. 2017 Jan 23;18(1):222. doi: 10.3390/ijms18010222.
4
Successful Treatment of an Aggressive Tracheal Malignancy With Immunotherapy.
Ann Thorac Surg. 2017 Feb;103(2):e123-e125. doi: 10.1016/j.athoracsur.2016.08.021.
5
MiR-320a effectively suppresses lung adenocarcinoma cell proliferation and metastasis by regulating STAT3 signals.
Cancer Biol Ther. 2017 Mar 4;18(3):142-151. doi: 10.1080/15384047.2017.1281497. Epub 2017 Jan 20.
7
10
Mechanism of c-Met and EGFR tyrosine kinase inhibitor resistance through epithelial mesenchymal transition in non-small cell lung cancer.
Biochem Biophys Res Commun. 2016 Sep 2;477(4):937-944. doi: 10.1016/j.bbrc.2016.07.003. Epub 2016 Jul 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验